CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 65 enrolled
Drug / intervention
TM Fill in combination with TM Flowdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06369779
NCT06369779N/AActive

Clinical Evaluation of Class I and II Cavities Restored With the Combination of a New Flowable and a New Sculptable Universal Bulk-fill Composite: A Prospective Single Arm Study

Ivoclar Vivadent AG·interventional·Posted Apr 17, 2024·Updated Oct 23, 2025

In Brief

A clinical study evaluating TM Fill in combination with TM Flow for Insufficient Dental Filling or Primary Caries (Class I or II Cavities in Premolars or Molars). Active but no longer recruiting, targeting 65 participants across 1 site.

Detailed Summary

The overall objective of this clinical investigation is to evaluate the clinical safety and performance of the new flowable composite TM Flow and the new sculptable composite TM Fill for restoration of class I and class II cavities. The fillings are assessed according to selected FDI (Fédération Dentaire Internationale) criteria at baseline (7-10 days after placement of filling) and after 1, 6, 12, 24, 36 and 60 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesLiechtenstein
Collaborators--

Timeline

N/AActive
2025202620272028202920302031
First PostedApr 17, 2024
Enrollment StartMay 13, 2024
Primary CompletionAug 12, 2024
Study CompletionDec 1, 2030
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 2.2 years ago

Interventions

TM Fill in combination with TM Flowdevice

The newly developed resin composites (TM Flow in combination with TM Fill) will be used for the restoration of class I and II cavities (3 seconds light-curing mode, 3000 milliwatt per square centimeter).